HCPCS Level IIprocedureActive
G9091
Onc dx rectal t3 n0 no prog
BETOS: P7B
Effective: 2007-01-01
Description
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t3, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
Medicare Fee Schedule
2026 Medicare Physician Fee Schedule national payment rates
$0.00
Non-Facility Price
$0.00
Facility Price
0.00
Work RVU
0.00
Total RVU (Non-Fac)